A recent Medical News Today article discussed a study that shed light on one of the benefits of cannabidiol (CBD), the part of cannabis that doesn’t produce a mind-altering effect. The study included 31 people between the ages 12 and 25 who met the criteria for a DSM-5 anxiety disorder and were unable to improve their condition with other treatments. Over a period of 12 weeks, participants received doses as high as 800 mg/d. By the end of the three months, participants saw a 40% decrease in anxiety severity based on the Overall Anxiety Severity and Impairment Scale.
